Clayton W. Jackson

Hematology
2201 Inwood Rd
Dallas, TX 75235

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Journal: Leukemia research
Published: April 14, 2026

Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene.

Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene.

Journal: Blood
Published: September 19, 2025

Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Journal: Blood
Published: September 19, 2025

Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohort.

Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohort.

Journal: Leukemia & lymphoma
Published: March 07, 2025

Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginase.

Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginase.

Journal: Blood vessels, thrombosis & hemostasis
Published: October 28, 2024

Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia.

Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia.

Journal: European journal of haematology
Published: October 02, 2024

A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia.

A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia.

Journal: Blood
Published: April 10, 2024

Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.

Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.

Journal: Cancers
Published: September 24, 2021

Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.

Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.

Journal: International journal of molecular sciences
Published: September 16, 2021

Pruritic Rash in a Woman With Hodgkin Lymphoma.

Pruritic Rash in a Woman With Hodgkin Lymphoma.

Journal: JAMA oncology
Published: February 08, 2019
Showing 1-10 of 10

Last Updated: 09/26/2026